{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:13:23Z","timestamp":1789402403598,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/aog.0b013e318237caf4","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T05:52:18Z","timestamp":1321941138000},"page":"1222-1229","source":"Crossref","is-referenced-by-count":45,"title":["The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy"],"prefix":"10.1097","volume":"118","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210328","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":". CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R2-4-20210328","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.","volume":"127","author":"Castle","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R3-4-20210328","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review.","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"R4-4-20210328","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Solomon D; ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R5-4-20210328","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/cncr.25635","article-title":". Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia : a randomized trial in Canada and Brazil.","volume":"117","author":"Elit","year":"2010","journal-title":"Cancer"},{"key":"R6-4-20210328","first-page":"1763","article-title":"Natural history of established low grade cervical intraepithelial (CIN 1) lesions.","volume":"28","author":"Bansal","year":"2008","journal-title":"Anticancer Res"},{"key":"R7-4-20210328","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1159\/000328554","article-title":"ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.","volume":"44","author":"Schiffman","year":"2000","journal-title":"Acta Cytol"},{"key":"R8-4-20210328","first-page":"397","article-title":"The Atypical Squamous Cells of Undetermined SignificanceLow-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R9-4-20210328","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","article-title":"A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R10-4-20210328","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R11-4-20210328","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Tarone R; ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R12-4-20210328","first-page":"779","article-title":"From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.","volume":"77","author":"Kurman","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R13-4-20210328","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":". The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R14-4-20210328","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests published erratum appears in J Low Genit Tract Dis 2008;12:255.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R15-4-20210328","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ published erratum appears in J Low Genit Tract Dis 2008;12:63.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R16-4-20210328","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1309\/BA43HMCAJ26VWQH3","article-title":"Interlaboratory reliability of Hybrid Capture 2.","volume":"122","author":"Castle","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R17-4-20210328","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/E067X0L1U3CY37NW","article-title":"Castle PE; ALTS Group. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.","volume":"124","author":"Schiffman","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R18-4-20210328","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":". A review of human carcinogensPart B: biological agents.","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"R20-4-20210328","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"A Wilcoxon-type test for trend.","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat Med"},{"key":"R21-4-20210328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/lgt.0b013e31815ea58b","article-title":"Risk assessment to guide the prevention of cervical cancer.","volume":"12","author":"Castle","year":"2008","journal-title":"J Low Genit Tract Dis"},{"key":"R22-4-20210328","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R23-4-20210328","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":". Number of cervical biopsies and sensitivity of colposcopy.","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R24-4-20210328","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2006.01.091","article-title":"Colposcopy at a crossroads.","volume":"195","author":"Jeronimo","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R25-4-20210328","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":". Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R26-4-20210328","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2.","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201112000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:13Z","timestamp":1786047793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201112000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e318237caf4","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}